Sign In
Buy BHVN
Biohaven Pharmaceutical Holding Company Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be positive at 99.68. In total, the insiders bought 7.92M and sold 55.56K BHVN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
99.68 |
| ● Buy | 7.92M shares |
| ● Sell | 55.56K shares |
|
85% Buy Activity
Weak Positive Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Apr 28, 2026 Buy |
Gregory Julia P Director |
68 693 Value: $660.1K |
||
|
Apr 28, 2026 Buy |
Mehta Kishan Director |
68 693 Value: $660.1K |
||
|
Apr 28, 2026 Buy |
Bailey Gregory Director |
68 693 Value: $660.1K |
||
|
Apr 28, 2026 Buy |
Heffernan Michael Thomas Director |
68 693 Value: $660.1K |
||
|
Apr 28, 2026 Buy |
Antonijevic Irina Director |
68 693 Value: $660.1K |
||
|
Apr 28, 2026 Buy |
Childs John W Director |
68 693 Value: $660.1K |
||
|
Apr 28, 2026 Buy |
Hugin Robert J Director |
68 693 Value: $660.1K |
||
|
Mar 17, 2026 Buy |
Mehta Kishan Director |
17 342 Value: $165.3K |
||
|
Mar 17, 2026 Sell |
Mehta Kishan Director |
17 342 Value: $0 |
||
|
Feb 27, 2026 Buy |
Coric Vlad Chief Executive Officer |
550 000 Value: $6.34M |
||
|
Feb 27, 2026 Buy |
Car Bruce Chief Scientific Officer |
175 000 Value: $2.02M |
||
|
Feb 27, 2026 Buy |
Buten Matthew Chief Financial Officer |
175 000 Value: $2.02M |
||
|
Feb 27, 2026 Buy |
Gentile Kimberly SVP, Clinical Operations |
175 000 Value: $2.02M |
||
|
Feb 27, 2026 Buy |
Clark George C. Vp, Chief Accounting Officer |
50 000 Value: $576.0K |
||
|
Jan 05, 2026 Buy |
Clark George C. Vp, Chief Accounting Officer |
2 500 Value: $24.8K |
||
|
Jan 05, 2026 Buy |
Clark George C. Vp, Chief Accounting Officer |
2 500 Value: $24.8K |
||
|
Jan 05, 2026 Buy |
Car Bruce Chief Scientific Officer |
4 750 Value: $47.2K |
||
|
Jan 05, 2026 Buy |
Coric Vlad Chief Executive Officer |
14 250 Value: $141.5K |
||
|
Jan 05, 2026 Buy |
Coric Vlad Chief Executive Officer |
14 250 Value: $141.5K |
||
|
Jan 05, 2026 Sell |
Buten Matthew Chief Financial Officer |
2 594 Value: $25.8K |
||
|
Jan 05, 2026 Buy |
Buten Matthew Chief Financial Officer |
4 250 Value: $42.2K |
||
|
Jan 05, 2026 Buy |
Gentile Kimberly SVP, Clinical Operations |
3 750 Value: $37.2K |
||
|
Jan 05, 2026 Sell |
Gentile Kimberly SVP, Clinical Operations |
1 956 Value: $19.4K |
||
|
Jan 05, 2026 Buy |
Gentile Kimberly SVP, Clinical Operations |
3 750 Value: $37.2K |
||
|
Jan 05, 2026 Buy |
Buten Matthew Chief Financial Officer |
4 250 Value: $42.2K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
